Home Financial Markets Penny Stocks The RGBP Stock Rose By 571% In Its Last Session. Can We...

The RGBP Stock Rose By 571% In Its Last Session. Can We Explain This?

Regen Biopharma, Inc. (OTCPink: RGBP) closed at a price of $0.0141 an increase of 571.43%. Regen Biopharma stock volume amounted to 3.52B, compared with its average weekly volume of 115M. A couple of intellectual property agreements involving cancer treatments have led to the RGBP stock rising.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What was the agreement for?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Regen BioPharma specializes in developing small molecule treatments for cancer and autoimmune disorders on the US market. For oncology and autoimmune diseases, RGBP plans to develop the small molecule NR2F6 that stimulates immune cell activation.

Read More

Regen Biopharma entered into an intellectual property (IP) agreement with Oncology Pharma in April 2021, as declared the RGBP in a SEC filing. The IP agreement between Regen and Oncology Pharma provides a license to develop and commercialize certain intellectual property exclusively.

The following is Oncology Pharma’s obligation for the license granted by RGBP under the Agreement:

  • RGBP will receive a fee of $55,000 no later than April 20, 2021, from Oncology Pharma.
  • RGBP will be paid royalties equal to five percent (5%) of the Net Sales of any Licensed Products in a quarter by Oncology Pharma.
  • Regen Bippharma (RGBP) will receive ten percent (10%) of all consideration Oncology Pharma receives from its sublicensees, the royalty being the equivalent of Net Sales for the Licensed Products that RGBP receives payment for.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Intellectual property of RGBP:

According to the IP agreement of Regen Bippharma (RGBP), the treatment for pancreatic cancer in humans would last for 15 years starting from April 7, 2021. An antigen-specific cancer vaccine using modified mRNA in which epitopes can be produced to boost immunity will arise under the License IP. Epitopes are parts of antigens that immune systems recognize and basis of vaccine developed by RGBP.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Is BTZI Stock Increasing Today?

The stock price of BOTS, Inc. (OTCPink: BTZI) has been rising more than 7% today and was buoying at $0.1266 at the last check....

Why Has The KBSF Stock Price Gained 10% In Last Session?

As of Friday's normal trading session, the price of KBS Fashion Group Limited (NASDAQ: KBSF) rose $0.26 or 9.96% to conclude at $2.87. KBS...

Why Royal Bank of Canada (RY) stock plummeted in after-hours on Friday?

Royal Bank of Canada (RY) stock lost 64.36% in the extended hour trading session on Friday, April 16, 2021. The RY stock gained merely...

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

Why Progyny Inc (PGNY) stock gained on Thursday, April 15?

Progyny Inc (PGNY) stock gained 7.31% in the after-hours session on Thursday, April 15, 2021, after it gained 0.94% in the early session.  PGNY...

Is This Why The APLD Stock Skyrocketed Last Trading?

Applied Science Products, Inc. (OTCPK: APLD) closed at $0.635 and experienced a 215.92% increase on Friday. A total of 2.07M shares of Applied Science...

The CRSS Stock Increased 82% In The Last Session Due To What?

Stock of Crossroads Systems, Inc. (OTCQX: CRSS) gained 81.82% or $18.00 in Friday's trading session, closing the day at $40.00 a share. Crossroads Systems...

How Did The ZVO Stock Appreciate 9% In The Last Trading Session?

Zovio Inc (NASDAQ: ZVO) normally sees about 413.34K shares traded on a regular business day but on a Friday it saw a bit higher...

Related News

Is This Why The APLD Stock Skyrocketed Last Trading?

Applied Science Products, Inc. (OTCPK: APLD) closed at $0.635 and experienced a 215.92% increase on Friday. A total of 2.07M shares of Applied Science...

The CRSS Stock Increased 82% In The Last Session Due To What?

Stock of Crossroads Systems, Inc. (OTCQX: CRSS) gained 81.82% or $18.00 in Friday's trading session, closing the day at $40.00 a share. Crossroads Systems...

SWRM Stock Increased 127% Last Session. What Was The Reason?

Stocks of AppSwarm, Corp. (OTC: SWRM) rose by 127.20% during the trading period on Friday, hitting a low of $0.011 and a high of...

What Drove The RECAF Stock Up 38% During Last Trading?

The shares of Reconnaissance Energy Africa Ltd. (OTCQX: RECAF) closed up 38.34 percent on Monday at $6.10, and have been trading between $4.55 and...

How Did The ALYI Stock Rocket In The Last Session, Jumping 15%?

At the close of trading on Friday, Alternet Systems, Inc. closed at $0.05945, up 14.77%. A total share volume of 60.88M was recorded by...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.